Recruiting

Observational Study

Sponsor:

QHSLab, Inc.

Code:

NCT06623799

Conditions

Mental Health Conditions

Allergic

Eligibility Criteria

Sex: All

Age: 4 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

This study explores how help-seeking behaviors for both emotional well-being and allergies impact the management of allergic rhinitis, asthma, and mental health symptoms, including anxiety and depression. The research involves a retrospective and longitudinal analysis of patients who sought treatment for allergic rhinitis and mental health concerns. The goal is to highlight the importance of integrating mental health care into allergy treatment plans to improve overall patient outcomes.

Conditions

Mental Health Conditions

Allergic

Study ID

NCT06623799

Start date

Jan 1, 2020

Status verified date

Feb, 2026

Completion date

Jan 25, 2027

Anticipated

Primary completion date

Jan 25, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 4 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

Adults (aged 18 years or older) Patients actively receiving care in a primary care setting. Patients who have provided informed consent for their health data to be included in the research repository.

Exclusion Criteria:

Patients who have not provided informed consent for their health data to be included in the research repository.

Patients diagnosed with chronic conditions outside the scope of allergic rhinitis, asthma, or mental health conditions (anxiety, depression).

Patients with severe mental health disorders or comorbidities that are unrelated to the conditions of interest (e.g., schizophrenia, bipolar disorder, etc.).

Study Design

Enrollment

200000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Change in Allergic Rhinitis Symptom Severity (SNOT-22 Score) [ Time Frame: baseline and yearly follow-up for up to 5 years ]

Central Contacts and Locations

Central contacts

Marcos A Sanchez-Gonzalez, MD, PhD

850-559-7676masanchez@qhslab.com

Troy Grogan

troy.grogan@usaqcorp.com

Locations

QHSLab

Recruiting

West Palm Beach, Florida, United States, 33407

Contacts

Marcos A Sanchez-Gonzalez, MD, PhD

8505597676masanchez@qhslab.com

Troy Grogan

(929) 379-6503troy.grogan@usaqcorp.com

Principal Investigator:

Marcos A Sanchez-Gonzalez, MD, PhD

More Information

Sponsor

QHSLab, Inc.

Last update posted

Feb 11, 2026

Last verified

Feb, 2026

Keywords

  • Allergic Rhinitis
  • Asthma Control
  • Mental Health
  • Help-Seeking Behaviors
  • Integrated Care

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by QHSLab, Inc. on 2026-02-11.